EU approves aortic heart valve from Sorin Group

02/3/2011 | CardiovascularBusiness.com

Sorin Group has been granted CE Mark approval for its aortic valve replacement device, the Perceval S, designed for aortic stenosis patients. Surgeons testing the device in a clinical study were able to perform isolated and complex valve replacement procedures in half the time the traditional method takes, the company said.

View Full Article in:

CardiovascularBusiness.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX